A23V2250/7106

S-beta-hydroxybutyrate compounds and compositions enriched with S-enantiomer
11185518 · 2021-11-30 · ·

Ketogenic compositions include a mixture of optically pure S-beta-hydroxybutyrate salts and acid(s) or non-racemic mixture of beta-hydroxybutyrate salts and acid(s) enriched with the S-enantiomer. The S-beta-hydroxybutyrate enantiomer modulates the effect of ketone bodies in the subject and controls the rate at which ketosis is achieved. Beta-hydroxybutyric acid is more rapidly absorbed and utilized by the body than salts or esters, enhances taste, and reduces the need to include citric acid or other edible acids. Beta-hydroxybutyrate salts are more slowly absorbed and utilized by the body and can provide one or more electrolytes. Compositions for controlling ketone body level in a subject may contain a dietetically or pharmaceutically acceptable carrier and optically pure S-beta-hydroxybutyrate or non-racemic mixture enriched with S-beta-hydroxybutyrate, wherein the compositions contains from about 50.5% to 100% by enantiomeric equivalents of S-beta-hydroxybutyrate and from about 49.5% to 0% by enantiomeric equivalents of R-beta-hydroxybutyrate.

DIETARY MACRO/MICRONUTRITIONAL SUPPLEMENT FOR PATIENTS UNDERGOING KIDNEY DIALYSIS
20210353578 · 2021-11-18 ·

Provided herein is a nutritional supplement designed to support kidney and cardiac function as well as mitochondrial energy function needs in patients undergoing hemodialysis. This supplement replenishes essential vitamins and minerals that are lost during dialysis, does not contain compounds that may specifically cause harm to dialysis patients, and provides support for tissues undergoing oxidative stress.

DIETARY MACRO/MICRONUTRITIONAL SUPPLEMENT FOR PATIENTS UNDERGOING KIDNEY DIALYSIS
20210353578 · 2021-11-18 ·

Provided herein is a nutritional supplement designed to support kidney and cardiac function as well as mitochondrial energy function needs in patients undergoing hemodialysis. This supplement replenishes essential vitamins and minerals that are lost during dialysis, does not contain compounds that may specifically cause harm to dialysis patients, and provides support for tissues undergoing oxidative stress.

Nutritional formulations and kits for bariatric individuals
11213059 · 2022-01-04 · ·

The present technology relates to a nutritional formulation for administration to bariatric individuals. The nutritional formulation includes a multi-nutrients dosage unit; and a minerals dosage unit.

CHOLECALCIFEROL FOR USE IN THE TREATMENT OF CELIAC DISEASE
20220273676 · 2022-09-01 · ·

The use of cholecalciferol is described as an active agent in the treatment of celiac disease, in the reduction of intestinal villous atrophy, and in the protection and regeneration of the intestinal epithelium. Also described are pharmaceutical compositions or food supplements, as well as foods for celiacs, including cholecalciferol and suitable excipients for use in the treatment of celiac disease, in the reduction of intestinal villous atrophy and in the protection and regeneration of the intestinal epithelium.

CHOLECALCIFEROL FOR USE IN THE TREATMENT OF CELIAC DISEASE
20220273676 · 2022-09-01 · ·

The use of cholecalciferol is described as an active agent in the treatment of celiac disease, in the reduction of intestinal villous atrophy, and in the protection and regeneration of the intestinal epithelium. Also described are pharmaceutical compositions or food supplements, as well as foods for celiacs, including cholecalciferol and suitable excipients for use in the treatment of celiac disease, in the reduction of intestinal villous atrophy and in the protection and regeneration of the intestinal epithelium.

Multivitamin extrudates
11278046 · 2022-03-22 · ·

This invention relates generally to multivitamin extrudates. Their production as well as their use.

Nutritional compositions comprising neuroprotective dietary oligosaccharides
11160817 · 2021-11-02 · ·

A nutritional composition for use in providing a neuroprotective effect to an individual in need thereof which nutritional composition comprises at least one human milk oligosaccharide selected from lacto-N-neotetraose and 2′-fucosyllactose.

Nutritional compositions comprising neuroprotective dietary oligosaccharides
11160817 · 2021-11-02 · ·

A nutritional composition for use in providing a neuroprotective effect to an individual in need thereof which nutritional composition comprises at least one human milk oligosaccharide selected from lacto-N-neotetraose and 2′-fucosyllactose.

Dietary macro/micronutritional supplement for patients undergoing kidney dialysis
11077085 · 2021-08-03 · ·

Provided herein is a nutritional supplement designed to support kidney and cardiac function as well as mitochondrial energy function needs in patients undergoing hemodialysis. This supplement replenishes essential vitamins and minerals that are lost during dialysis, does not contain compounds that may specifically cause harm to dialysis patients, and provides support for tissues undergoing oxidative stress.